StockNews.com assumed coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research note published on Saturday. The firm issued a hold rating on the biotechnology company’s stock.
Just eight months after undergoing robotic surgery to remove his cancerous prostate, Mark Cwiek, a 70-year-old track and ...
Two Cork dairy farmers share their experience as volunteer drivers for patients receiving cancer treatment with the charity ...
A new study from Edith Cowan University reveals that regular exercise can reduce the recurrence rates of breast cancer by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results